Development of biodegradable ioxilan carbonate particles for contrast enhancement of the liver in computed tomography scanning: toxicity assessment.
Li
C
C
Division of Diagnostic Imaging, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA.
McCuskey
P
P
Yang
D J
DJ
Kan
Z
Z
Wallace
S
S
D000818:Animals; D002254:Carbonates / Q000493:pharmacokinetics / Q000633:toxicity*; D003287:Contrast Media / Q000493:pharmacokinetics / Q000633:toxicity*; D005260:Female; D007472:Iohexol / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000633:toxicity; D007668:Kidney / Q000187:drug effects*; D007677:Kidney Function Tests; D008099:Liver / Q000000981:diagnostic imaging*; D008111:Liver Function Tests; D011355:Prodrugs / Q000493:pharmacokinetics / Q000633:toxicity*; D051381:Rats; D017207:Rats, Sprague-Dawley; D014057:Tomography, X-Ray Computed
D002254:Carbonates; D003287:Contrast Media; D011355:Prodrugs; D007472:Iohexol; C055357:ioxilan